Free Trial
NASDAQ:VRNM

(VRNM) (VRNM) Stock Price, News & Analysis

→ The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad)
Free VRNM Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
240,414 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
VRNM stock logo

About (VRNM) Stock (NASDAQ:VRNM)

Verenium Corporation (Verenium) is an industrial biotechnology company. The Company develops and commercializes enzymes for use in a range of industrial processes. It manufactures and markets its enzyme products in the fields of animal health and nutrition, grain processing, oilfield services and other industrial processes, such as pulp and paper and textiles. As of December 31, 2012, it marketed commercial enzyme products, either independently or in collaboration with its partners. In addition, it has developed a pipeline of enzyme product candidates. Its products are organized into four product lines: animal health and nutrition, grain processing, oilfield services and other industrial processes. As of December 31, 2012, it markets nine commercial enzyme products. In October 2013, BASF SE acquired 71% stake in the Company.

VRNM Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive VRNM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (VRNM) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:VRNM
CUSIP
N/A
CIK
1049210
Web
N/A
Phone
+1-858-4318500
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2024 Cover
The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • James H. Cavanaugh Ph.D. (Age 77)
    Independent Chairman of the Board
  • James E. Levine (Age 43)
    President, Chief Executive Officer, Director
  • Jeffrey G. Black (Age 48)
    Chief Financial Officer, Senior Vice President
  • Janet S. Roemer (Age 57)
    Chief Operating Officer, Executive Vice President - Specialty Enzymes Business Unit
  • Alexander A. Fitzpatrick (Age 47)
    Senior Vice President, General Counsel, Secretary
  • John F. Dee (Age 56)
    Independent Director
  • Peter R Johnson (Age 61)
    Independent Director
  • Fernand J. Kaufmann (Age 70)
    Independent Director
  • Holger A. Liepmann (Age 63)
    Independent Director
  • Joshua Ruch
    Independent Director

This page (NASDAQ:VRNM) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners
SHOCKING Crypto Leak…
Crypto 101 Media
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
Banyan Hill Publishing
Man Who Predicted 2008: “This Will be Worse.”
Altimetry
Biden out June 13; Kamala won’t replace him?
Paradigm Press
Fed launches fourth dollar overhaul
Stansberry Research
The Greatest Bull Market in Crypto History…
Weiss Ratings